Literature DB >> 28246430

Drugs for chronic obstructive pulmonary disease.

Christine Jenkins1.   

Abstract

Entities:  

Keywords:  COPD (chronic obstructive pulmonary disease); antimuscarinics; beta agonists; corticosteroids

Year:  2017        PMID： 28246430      PMCID： PMC5313246          DOI： 10.18773/austprescr.2017.003

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  50 in total

Review 1.  Influenza vaccine for patients with chronic obstructive pulmonary disease.

Authors:  P J Poole; E Chacko; R W B Wood-Baker; C J Cates
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

2.  Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study.

Authors:  Paul W Jones; Dave Singh; Eric D Bateman; Alvar Agusti; Rosa Lamarca; Gonzalo de Miquel; Rosa Segarra; Cynthia Caracta; Esther Garcia Gil
Journal:  Eur Respir J       Date:  2012-03-22       Impact factor: 16.671

3.  β-blockers for COPD inpatients.

Authors:  Samy Suissa; Pierre Ernst
Journal:  Thorax       Date:  2012-11       Impact factor: 9.139

4.  Understanding the GOLD 2011 Strategy as applied to a real-world COPD population.

Authors:  Jørgen Vestbo; Claus Vogelmeier; Mark Small; Victoria Higgins
Journal:  Respir Med       Date:  2014-03-14       Impact factor: 3.415

Review 5.  Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease.

Authors:  Charlotta Karner; Christopher J Cates
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

6.  Smoking and lung function of Lung Health Study participants after 11 years.

Authors:  Nicholas R Anthonisen; John E Connett; Robert P Murray
Journal:  Am J Respir Crit Care Med       Date:  2002-09-01       Impact factor: 21.405

Review 7.  Update on medicines for smoking cessation.

Authors:  Mike McDonough
Journal:  Aust Prescr       Date:  2015-08-03

8.  Withdrawal of inhaled glucocorticoids and exacerbations of COPD.

Authors:  Helgo Magnussen; Bernd Disse; Roberto Rodriguez-Roisin; Anne Kirsten; Henrik Watz; Kay Tetzlaff; Lesley Towse; Helen Finnigan; Ronald Dahl; Marc Decramer; Pascal Chanez; Emiel F M Wouters; Peter M A Calverley
Journal:  N Engl J Med       Date:  2014-09-08       Impact factor: 91.245

9.  Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD.

Authors:  Ian D Pavord; Sally Lettis; Nicholas Locantore; Steve Pascoe; Paul W Jones; Jadwiga A Wedzicha; Neil C Barnes
Journal:  Thorax       Date:  2015-11-19       Impact factor: 9.139

10.  A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC).

Authors:  Marc Miravitlles; Juan José Soler-Cataluña; Myriam Calle; Jesús Molina; Pere Almagro; José Antonio Quintano; Juan Antonio Trigueros; Pascual Piñera; Adolfo Simón; Juan Antonio Riesco; Julio Ancochea; Joan B Soriano
Journal:  Prim Care Respir J       Date:  2013-03
View more
  2 in total

Review 1.  Managing the overlap of asthma and chronic obstructive pulmonary disease.

Authors:  Anne Knight
Journal:  Aust Prescr       Date:  2020-02-03

2.  Efficiency of Nebulizing Furosemide in the Treatment of Chronic Pulmonary Obstructive Disease: A Systematic Review and Meta-Analysis of Clinical Trials.

Authors:  Abas Ghaysouri; Gholam Basati; Morteza Shams; Hamed Tavan
Journal:  Tanaffos       Date:  2020-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.